Are you asking about the CAR-T cell therapy process for myeloma? Here's a breakdown of how it works:
CAR-T cell therapy is a type of immunotherapy that helps your immune system fight myeloma more effectively. It involves several key steps:
1. T cell collection – A machine removes blood from your body, separates out your T Show Full Answer
Are you asking about the CAR-T cell therapy process for myeloma? Here's a breakdown of how it works:
CAR-T cell therapy is a type of immunotherapy that helps your immune system fight myeloma more effectively. It involves several key steps:
1. T cell collection – A machine removes blood from your body, separates out your T cells (immune cells), and returns the rest of your blood back to you. This is called apheresis.
2. Lab engineering – Your T cells are sent to a lab where they are genetically modified to recognize and attack myeloma cells. This process can take up to three weeks.
3. Lymphodepletion – Before receiving your new T cells back, you'll go through a short round of chemotherapy to clear space and help the new cells work better.
4. Infusion – The modified CAR-T cells are infused back into your body through an IV.
5. Monitoring – You'll typically stay in the hospital for several weeks so doctors can check that the treatment is working and manage any side effects. After being discharged, you may need to stay close to your treatment center for a month or more in case any complications arise.
The modified T cells can remain in your body for many months, continuing to seek out and destroy myeloma cells — making it more of an ongoing defense system than a one-time treatment.
It's worth noting that CAR-T cell therapy can cause serious side effects, so close monitoring by your medical team is really important throughout the process. Always discuss the risks and benefits with your doctor to see if this option is right for you.
September 27
Join
Your Privacy Choices
